Sleep Tracker
Effectiveness supported by 2+ PSG validation studies (e.g., Ding 2022: high sleep stage agreement; Kushida 2023/Wanchaitanawong 2025: high OSA sensitivity in large datasets), comparable to PSG gold standard. Safety excellent with zero adverse reports across PubMed/FDA searches and FCC compliance. Quality dragged down by discontinuation (Beautyrest partnership ended 2024, app unusable for new users, security patches required but support ceased). Overall average due to obsolescence despite solid t
Beautyrest Sleeptracker offers validated non-wearable sleep tracking (PSG agreement per Ding 2022) but is obsolete: discontinued with ended app support, rendering new purchases unusable. Suitable only for existing patched users accessing historical data. Avoid for new buyers.